BTG is an international specialty pharmaceuticals company that is
developing and commercialising products targeting critical care,
cancer, neurological and other disorders. The company is also seeking
to acquire new products to develop and market to hospital specialists,
and is building a sustainable business financed by revenues from sales
of its critical care products and from royalties and milestone payments
on partnered products.
|